ameystelman

About ITM TwentyFirst

This author has not yet filled in any details.
So far ITM TwentyFirst has created 17 blog entries.

Noted Economist to Discuss Economic Impact of Covid-19 at Fasano Conference

Noted Economist to Discuss Economic Impact of Covid-19 at Fasano Conference Noted economist and fiscal policy expert, Eugene Steuerle, will discuss The Implications of Covid-19 for the Economy and Government Policy at the 2020 Fasano Life Settlement & Longevity Conference on Monday, November 2nd. [...]

Noted Economist to Discuss Economic Impact of Covid-19 at Fasano Conference2020-10-15T17:26:18-04:00

Long-Term Mortality Impact of COVID-19 at Fasano Longevity Conference

Long-Term Mortality Impact of COVID-19 at Fasano Longevity Conference Andrew Cairns and Stuart McDonald will present their views on the Long-Term Mortality Impact of COVID-19 at the November 2nd Fasano Longevity Conference in Washington, DC. Dr. Cairns is Professor of Financial Mathematics at Heriot-Watt University in Edinburgh and [...]

Long-Term Mortality Impact of COVID-19 at Fasano Longevity Conference2020-10-11T18:42:41-04:00

Groundbreaking Geneticist to Keynote Fasano Longevity Conference

Groundbreaking Geneticist to Keynote Fasano Longevity Conference Dr. Steve Horvath will deliver the Keynote Presentation on Epigenetics and Biomarkers: A New Age in Longevity Modeling at the November 2nd Fasano Longevity Conference in Washington, DC. Dr. Horvath, UCLA Professor in Human Genetics and Biostatistics, is the developer of [...]

Groundbreaking Geneticist to Keynote Fasano Longevity Conference2020-09-24T21:28:28-04:00

Private Equity Perspective on Life Settlements at November 2nd Fasano Longevity Conference

THE 2020 FASANO LONGEVITY CONFERENCE: Private Equity Perspective on Life Settlements Kurt Bolin, Principal at Stone Point Capital, will present his views on the longevity and life settlement markets at the November 2nd Fasano Longevity Conference in Washington, DC. Stone Point Capital LLC is a [...]

Private Equity Perspective on Life Settlements at November 2nd Fasano Longevity Conference2020-09-24T21:28:55-04:00

2020 FASANO LONGEVITY CONFERENCE: BEST VALUE EVER!

THE 2020 FASANO LONGEVITY CONFERENCE: BEST VALUE EVER! Its Virtual: No cocktails or dinner this year; but we will make it feel real with live Q&A following every presentation All Substance: Our Agenda this year maintains Fasano's preeminence in delivering fresh, relevant presentations affecting the longevity markets. Topics will include: Epigenetics and Biomarkers: A [...]

2020 FASANO LONGEVITY CONFERENCE: BEST VALUE EVER!2020-09-24T21:33:06-04:00

Evaluating Life Expectancy Evaluations – Daniel Bauer, Michael V. Fasano, Jochen Russ & Nan Zhu

The quality of life expectancy estimates is one key consideration for an investor in life settlements. The predominant metric for assessing this quality is the so-called A-to-E ratio, which relies on a comparison of the actual to the predicted number of deaths. In this article, we explain key issues with this metric: In the short [...]

Evaluating Life Expectancy Evaluations – Daniel Bauer, Michael V. Fasano, Jochen Russ & Nan Zhu2020-09-24T21:33:59-04:00

Structured Settlement Underwriting Performance: Implications for Short Form Life Settlement Underwriting?

This month we are publishing Actual to Expected performance results for our Structured Settlement underwriting business.  The results are good, with an Actual to Expected ratio of 98% for the 2012 through 2016 period, assuming IBNR of 7%.  Without IBNR, the A to E ratio would be 91%. But the real story here is not the results, [...]

Structured Settlement Underwriting Performance: Implications for Short Form Life Settlement Underwriting?2020-09-24T21:17:09-04:00

Fasano Discusses New Tools in Risk Analysis

Fasano Associates President, Mike Fasano, discusses the valuable new medical information that will be available from wearable devices, as well as possible underwriting applications for Big Data analyses. If you are unable to view this link, please contact us at techsupport@fasanoassociates.com or 202-457-8188.

Fasano Discusses New Tools in Risk Analysis2020-09-24T21:16:42-04:00